Personal Injury Lawyers
Toll Free 24/7
877-DRUG-GIANT
(877) 378-4442 816-LAW-FIRM
(816) 529-3476

Pharmaceutical Litigation

Medical Devices

Personal Injury

Nursing Home Litigation

Pollutants & Toxic Chemical Exposure

Defective & Recalled Products

Medical Malpractice

CONSUMER PROTECTION

Pharmaceutical Litigation

HEPARIN

Manufacturer: Baxter International
Uses: Widely used as an injectable anticoagulant


More Information

Paxil
Heparin Bottles

Recently, the FDA warned that Baxter International manufactured Heparin, a commonly used blood thinner, may have been contaminated. Heparin is used as a blood clotting preventative during surgery and during hemodialysis. The FDA recently reported a substantial increase in deaths of people using this Heparin.

If you or someone you know had any adverse reaction after undergoing kidney dialysis or surgery after being administered Heparin, you may be entitled to substantial monetary compensation. For a free consultation, contact Peterson & Associates toll free at 877-DRUG-GIANT, or click here.


Click Here For A Free Case Evaluation

Watch Our Video
You need to upgrade your Flash Player Click here to download the latest version of the Flash Player.
Click to Call to Speak with Our Injury Lawyers Today
FREE CASE REVIEW

We understand that you have questions and need answers. Our attorneys and staff are available to help you find the information you need.

Name:
Phone:
Email:
How did you hear about us?
Comment / Questions:

graphic
No Recovery No Fees
Recall News
DIGITEK RECALL!

The FDA has recalled all Digitek tablets after the discovery of manufacturing defects.  Individuals taking Digitek tablets may suffer from an illness known as Digitalis Toxicity and various other symptoms.  This manufacturing defect may cause serious health problems, and even death.   

Product Recall
NEWS HEADLINES
Recent Headlines
NEWS HEADLINES

The Peterson Foundation, Inc. was established by David M. Peterson to support children in need throughout the Kansas City area. For more information click here.

News